Research from Rutgers Health indicates that blood tests for Alzheimer's disease need to be interpreted with ...

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...

Explore the latest advancements in Alzheimer's treatment and the impact of new medications on patient independence and daily ...

Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared ...

Getting enough quality sleep may do more than just help you feel rested—it could play a critical role in protecting your ...

Researchers identify associations between B12 levels currently accepted as normal and markers of neurological injury or ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

While carrying the dreaded genetic variation that plagued his family members, he still has no symptoms of Alzheimer’s.

In the February 10 Nature Medicine, scientists led by Jorge Llibre-Guerra and Randall Bateman at Washington University, St.

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

It is estimated that about 60,000 people in the U.S. are currently living with FTD. Up to 40% of FTD cases have a genetic component and the patient receiving troculeucel is known to carry the C9orf72 ...

Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...